Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide

Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide

US Patent 10112991 · Granted Oct 30, 2018

Estimated economic value: $9,819,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceut2025
Modulators of alpha-1 antitrypsin2025
Crystalline forms of CFTR modulators2025
Trispecific binding proteins, methods, and uses thereof2025
Inhibitors of APOL1 and methods of using same2024
Modulators of alpha-1 antitrypsin2024
Crystalline forms of CFTR modulators2024
Anti-CD38 antibodies and formulations2023
Modulators of alpha-1 antitrypsin2023
Inhibitors of APOL1 and methods of using same2023
Trispecific binding proteins, methods, and uses thereof2023
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of u2022